Pivotport, Inc. has successfully completed its “Grow” (Level 3) stage in the Microsoft for Startup Founders program and has been granted approval by Microsoft to move up to the “Scale” (Level 4) stage with a grant of $150000 in Azure Credits as of August 15, 2024.
This opens up Pivotport’s ability to use Azure for its MVP to move into a fully architected system to capture, collect and detect Cardiac Anomalies using Visual Studio with Azure DevOps, Azure DevTest Labs with Azure DevBox, Github Enterprise, Azure IoT Hub, Azure Fabric, Azure AI Studio, Azure ML Workspace, Azure Quantum Workspace, M365 and Github CoPilots as well as M365 Business Premium.
Pivotport plans to use the granted Azure Credits over the next twelve month period via collaboration in Quantum Cardiac Anomaly Detection and Identification related pilot projects. Interested researchers and companies can reachout via emailing rajiv@pivotport.com to book a call to discuss how we might engage in such collaboration.
